SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tyche Industries shines on getting US FDA approval for its manufacturing facility in Andhra Pradesh

12 May 2016 Evaluate

Tyche Industries is currently trading at Rs. 49.10, up by 8.15 points or 19.90 % from its previous closing of Rs. 40.95 on the BSE.

The scrip opened at Rs. 49.10 and has touched a high and low of Rs. 49.10 and Rs. 49.10 respectively. So far 36921 shares were traded on the counter.

The BSE group 'XD' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.25 on 03-Nov-2015 and a 52 week low of Rs. 20.30 on 27-May-2015.

Last one week high and low of the scrip stood at Rs. 49.10 and Rs. 39.20 respectively. The current market cap of the company is Rs. 50.33 crore.

The promoters holding in the company stood at 62.20% while Non-Institutions held 37.80%.

Tyche Industries has received US Food and Drug Administration (US FDA) approval for its active pharmaceutical ingredients (API) manufacturing facility located in Kakinada, Andhra Pradesh.

The company manufactures and exports APIs, intermediates and nutraceuticals. The company posted a profit of Rs 23 lakh on a topline of Rs 14.16 crore for the quarter ended December 2015.

Tyche Inds Share Price

129.00 1.09 (0.85%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×